Marfan Syndrome Clinical Trial
Official title:
Clinical and Molecular Manifestations of Heritable Connective Tissue Disorders
The purposes of this study are to identify the genes responsible for inherited connective
tissue disorders and learn about the range of medical problems they cause. It will
investigate whether specific gene changes cause specific medical problems and will establish
diagnostic criteria (signs and symptoms) for the individual syndromes.
Children and adults with a known or suspected inherited connective tissue disorder (Marfan,
Ehlers-Danlos or Stickler syndrome, or other closely related disorders) and their family
members may be eligible for this study.
Patients enrolled in the study will have a medical history, physical examination and blood
tests, as well as other procedures that may include:
- Echocardiogram (ultrasound of the heart)
- X-rays and other imaging studies, such as magnetic resonance imaging (MRI) or
computerized tomography (CT) scans
- Lung function studies
- Urine tests
- Skin biopsy (removal of a small piece of tissue, under local anesthetic, for
microscopic examination)
- Examination by various specialists (e.g., in ophthalmology, gastroenterology,
rehabilitation medicine) as needed
- Questionnaires regarding chronic pain and fatigue, quality of life, and the impact of
the connective tissue disorder on the patient and family.
(Patients who wish to enroll but cannot travel to NIH may have a more limited participation,
including review of medical records, telephone interview regarding personal and family
history, and collection of a specimen (blood, skin biopsy, or other) for genetic testing.
Patients will be notified of genetic testing results that show a change responsible for
their connective tissue disorder. If they wish, the information will also be sent to their
local health care provider, along with recommendations for additional tests or treatment
options. No treatment is offered as part of this study.
Participating family members who do not themselves have a connective tissue disorder will
provide a small blood sample for gene testing and be interviewed by telephone about their
personal and family health history. Those whose blood test results show a gene change
associated with a connective tissue disorder will be invited to NIH for a discussion of the
findings or referred to a genetic center in their area.
We will investigate the clinical manifestations and molecular genetic defects of heritable connective tissue disorders, concentrating on the Marfan, Stickler, and Ehlers-Danlos syndromes. Although each of these conditions has been known for many years, the full spectrum of the associated phenotypes continues to be expanded and the genetic etiology of these conditions has not been completely elucidated. In addition, many patients have features overlapping two or more of the described syndromes, precluding unequivocal diagnosis. The goals of this study are to further define and characterize the full phenotype and natural history of these disorders, and to perform genetic linkage, gene identification, mutation detection, and genotype/phenotype correlations in affected individuals and families. Individuals suspected to have Marfan, Stickler or Ehlers-Danlos syndrome or a closely related disorder, as well as interested family members, will be enrolled. Participants will undergo genetic analyses and periodic clinical assessment. The expected outcomes will be improved clinical descriptions of the conditions and gene and mutation identification with analysis of genotype/phenotype correlations. ;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00763893 -
Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
|
Phase 3 | |
Recruiting |
NCT05809323 -
Marfan Syndrome Moderate Exercise Trial II
|
N/A | |
Completed |
NCT04776668 -
Living With Marfan Syndrome and Your Aorta
|
||
Recruiting |
NCT01949233 -
The Oxford Marfan Trial
|
Phase 2 | |
Active, not recruiting |
NCT01145612 -
Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
|
Phase 3 | |
Completed |
NCT00723801 -
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
|
Phase 3 | |
Completed |
NCT04641325 -
Marfan Syndrome Moderate Exercise Pilot
|
N/A | |
Recruiting |
NCT06257004 -
Genome-wide Epistasis for Cardiovascular Severity in Marfan Study
|
||
Completed |
NCT01322165 -
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
|
N/A | |
Recruiting |
NCT05700175 -
Transcriptomic Study of Adult Population With Marfan Syndrome
|
||
Completed |
NCT00782327 -
Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
|
Phase 3 | |
Not yet recruiting |
NCT05838235 -
Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome
|
N/A | |
Recruiting |
NCT02148900 -
Development of a Blood Test for Marfan Syndrome
|
N/A | |
Active, not recruiting |
NCT05980104 -
Single-Session "Empowered Relief" Class for Marfan Syndrome and Related Conditions
|
N/A | |
Recruiting |
NCT02050113 -
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
|
N/A | |
Completed |
NCT01715207 -
Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol
|
Phase 3 | |
Completed |
NCT05516043 -
Safety and Performance of POLYTHESE® Vascular Prosthesis
|
||
Recruiting |
NCT04776681 -
Living With Marfans and Your Aorta: Surgical Outcomes Study
|
||
Completed |
NCT03236571 -
Cardiorespiratory and Muscular Rehabilitation of Children and Young Adults With Marfan Syndrome.
|
N/A | |
Recruiting |
NCT00683124 -
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
|
Phase 3 |